Thoracic Empyema: A 12-Year Study from a UK Tertiary Cardiothoracic Referral Centre
Open Access
- 20 January 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (1), e30074
- https://doi.org/10.1371/journal.pone.0030074
Abstract
Empyema is an increasingly frequent clinical problem worldwide, and has substantial morbidity and mortality. Our objectives were to identify the clinical, surgical and microbiological features, and management outcomes, of empyema. A retrospective observational study over 12 years (1999–2010) was carried out at The Heart Hospital, London, United Kingdom. Patients with empyema were identified by screening the hospital electronic ‘Clinical Data Repository’. Demographics, clinical and microbiological characteristics, underlying risk factors, peri-operative blood tests, treatment and outcomes were identified. Univariable and multivariable statistical analyses were performed. Patients (n = 406) were predominantly male (74.1%); median age = 53 years (IQR = 37–69). Most empyema were community-acquired (87.4%) and right-sided (57.4%). Microbiological diagnosis was obtained in 229 (56.4%) patients, and included streptococci (16.3%), staphylococci (15.5%), Gram-negative organisms (8.9%), anaerobes (5.7%), pseudomonads (4.4%) and mycobacteria (9.1%); 8.4% were polymicrobial. Most (68%) cases were managed by open thoracotomy and decortication. Video-assisted thoracoscopic surgery (VATS) reduced hospitalisation from 10 to seven days (P = 0.0005). All-cause complication rate was 25.1%, and 28 day mortality 5.7%. Predictors of early mortality included: older age (P = 0.006), major co-morbidity (P = 0.01), malnutrition (P = 0.001), elevated red cell distribution width (RDW, PP = 0.004), and reduced serum albumin (P = 0.01) and haemoglobin (P = 0.04). Empyema remains an important cause of morbidity and hospital admissions. Microbiological diagnosis was only achieved in just over 50% of cases, and tuberculosis is a notable causative organism. Treatment of empyema with VATS may reduce duration of hospital stay. Raised RDW appears to associate with early mortality.Keywords
This publication has 44 references indexed in Scilit:
- Molecular Analysis Improves Pathogen Identification and Epidemiologic Study of Pediatric Parapneumonic EmpyemaThe Pediatric Infectious Disease Journal, 2011
- Positive predictive value of the ICD-10 hospital diagnosis of pleural empyema in the Danish National Registry of PatientsClinical Epidemiology, 2011
- Rapid Molecular Detection of Tuberculosis and Rifampin ResistanceThe New England Journal of Medicine, 2010
- Thoracic empyema: current opinions in medical and surgical managementCurrent Opinion in Pulmonary Medicine, 2010
- Thoracoscopic decortication vs tube thoracostomy with fibrinolysis for empyema in children: a prospective, randomized trialJournal of Pediatric Surgery, 2009
- Parapneumonic Empyema Deaths during Past Century, UtahEmerging Infectious Diseases, 2009
- Red Cell Distribution Width for Assessment of Activity of Inflammatory Bowel DiseaseDigestive Diseases and Sciences, 2008
- Bacteriology of complicated parapneumonic effusionsCurrent Opinion in Pulmonary Medicine, 2007
- U.K. Controlled Trial of Intrapleural Streptokinase for Pleural InfectionThe New England Journal of Medicine, 2005
- The clinical course and management of thoracic empyemaQJM: An International Journal of Medicine, 1996